Live Quote · NASDAQINDPHealthcare· Biotechnology

Indaptus Therapeutics, Inc.

$2.82▼ 9.90%($-0.31)
MKT CAP $319.34MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
54/100
▌ Mixed
60
Valuation
20
Profitability
60
Growth
72
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INDP research report →

Analyst RatingBuy
2 Buy0 Hold0 Sell

Price Chart

+61.14% · this period
$4.75$2.84$0.94Nov 20May 26Nov 20
52-Week Range38% of range
Low
$0.92
Current
$2.82
High
$5.96